Steady progress of ZIVO Bioscience, Inc. (ZIVO) Stock in Premarket


ZIVO Bioscience, Inc. (ZIVO), a research and development company, has seen an increase of 1.35% in the premarket trading session, as a result of which, ZIVO stock was trading at $3.76 when last checked. The gain has come after the company announced to participate in the upcoming global Ag Tech conference. On Wednesday, ZIVO stock declined 1.33% during regular hours and closed the day at $3.71.

Top 5 EV Tech Stocks to Buy for 2023

According a new report published by BloombergNEF on investment in the energy transition, annual spending on passenger EVs hit $388 billion in 2022, up 53% from the year before. Like we said, the boom is accelerating – and the time to buy EV-related tech stocks is now.

Click Here to Download the FREE Report.


ZIVO to participate in Global Ag-Tech conference

ZIVO announced on Wednesday that the company’s CEO Andrew A. Dahl had got a letter of invitation for his presence at the Global AgTech Virtual Conference. The conference is presented by Maxim Group LLC and would be hosted on October 14, 2021, by M-Vest. The company said that Andrew Dahl would present during the panel namely “The Health and Wellness Panel”. The event would consist of 4 virtual panels. The panels would constitute executive management from various multinationals in the Ag Tech sector.

ZIVO letter to shareholders

On 17th August, ZIVO issued a letter to its shareholders. CEO Andrew Dahl highlighted the outstanding financial performance of the company in the letter. He reiterated his commitment to move the company forward with commercialization efforts, which in turn would get support from technical and financial resources built by the company. He urged potential investors to show trust over the company and that it would prove quite rewarding for them in near future.

Q2 2021 financial results

In mid of August, ZIVO reported the financial results for the second quarter of the fiscal year 2021, ended 30th June 2021. According to those, the company had cash and cash assets of $10.90 million on 30th June. The total assets were $11.10 million, while total liabilities remained at $3.77 million. The total costs and expenses for three month period were $1.74 million, while for the equivalent three month period of 2020, these were $1.02 million. The net loss suffered by the company during the three months was $1.84 million, while during the comparative three month period of 2020; the net loss was $1.16 million. The net loss per basic and dilutes share were $0.28 and $0.23 during the second quarter of 2021 and 2020 respectively.

What lies ahead for ZIVO?

ZIVO stock has seen a declining trend in recent days, as evident from a 25% decline during last week. The main reason behind this decline appears to be short trading. In the long run, however, ZIVO stock is expected to show a stabilizing trend, mainly due to strong performance by the company during the recent past. So, investors should watch the stock closely.


Please enter your comment!
Please enter your name here